These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24666612)

  • 1. Effect of simvastatin on castration-resistant prostate cancer cells.
    Kim JH; Cox ME; Wasan KM
    Lipids Health Dis; 2014 Mar; 13():56. PubMed ID: 24666612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer.
    Nakayama H; Sekine Y; Oka D; Miyazawa Y; Arai S; Koike H; Matsui H; Shibata Y; Suzuki K
    Prostate; 2022 Feb; 82(3):314-322. PubMed ID: 34843630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase.
    Göbel A; Pählig S; Motz A; Breining D; Traikov S; Hofbauer LC; Rachner TD
    Biochem Biophys Res Commun; 2024 May; 710():149841. PubMed ID: 38588613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC).
    Kong Y; Cheng L; Mao F; Zhang Z; Zhang Y; Farah E; Bosler J; Bai Y; Ahmad N; Kuang S; Li L; Liu X
    J Biol Chem; 2018 Sep; 293(37):14328-14341. PubMed ID: 30089652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts.
    Gordon JA; Midha A; Szeitz A; Ghaffari M; Adomat HH; Guo Y; Klassen TL; Guns ES; Wasan KM; Cox ME
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):21-7. PubMed ID: 26238234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
    Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ
    Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin derivatives as therapeutic agents for castration-resistant prostate cancer.
    Ingersoll MA; Miller DR; Martinez O; Wakefield CB; Hsieh KC; Simha MV; Kao CL; Chen HT; Batra SK; Lin MF
    Cancer Lett; 2016 Dec; 383(1):94-105. PubMed ID: 27687622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.
    Villanueva JA; Sokalska A; Cress AB; Ortega I; Bruner-Tran KL; Osteen KG; Duleba AJ
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E455-62. PubMed ID: 23386644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model.
    Leon CG; Locke JA; Adomat HH; Etinger SL; Twiddy AL; Neumann RD; Nelson CC; Guns ES; Wasan KM
    Prostate; 2010 Mar; 70(4):390-400. PubMed ID: 19866465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
    Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
    J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
    Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
    Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
    Sivaprasad U; Abbas T; Dutta A
    Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP11A1 silencing suppresses HMGCR expression via cholesterol accumulation and sensitizes CRPC cell line DU-145 to atorvastatin.
    Tashiro J; Sugiura A; Warita T; Irie N; Dwi Cahyadi D; Ishikawa T; Warita K
    J Pharmacol Sci; 2023 Nov; 153(3):104-112. PubMed ID: 37770151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
    Neuwirt H; Bouchal J; Kharaishvili G; Ploner C; Jöhrer K; Pitterl F; Weber A; Klocker H; Eder IE
    Cell Commun Signal; 2020 Jan; 18(1):11. PubMed ID: 31980029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.
    Stine JE; Guo H; Sheng X; Han X; Schointuch MN; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2016 Jan; 7(1):946-60. PubMed ID: 26503475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
    Haslinger B; Kleemann R; Toet KH; Kooistra T
    Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.
    Babcook MA; Shukla S; Fu P; Vazquez EJ; Puchowicz MA; Molter JP; Oak CZ; MacLennan GT; Flask CA; Lindner DJ; Parker Y; Daneshgari F; Gupta S
    Mol Cancer Ther; 2014 Oct; 13(10):2288-302. PubMed ID: 25122066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.
    Kang M; Lee KH; Lee HS; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2017; 12(9):e0184644. PubMed ID: 28910332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis?
    Li H; Lewis A; Brodsky S; Rieger R; Iden C; Goligorsky MS
    Circulation; 2002 Mar; 105(9):1037-43. PubMed ID: 11877351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells.
    Miyazawa Y; Sekine Y; Oka D; Nakazawa S; Tsuji Y; Nakayama H; Suzuki K
    Anticancer Res; 2023 Dec; 43(12):5377-5386. PubMed ID: 38030198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.